EarlySense Nabs FDA Approval For Its Monitoring Chair

July 6, 2014 | The Israeli creator of a hospital bed monitoring device EarlySense received U.S. Food & Drug Administration approval for its monitoring chair. FDA approval will allow the company to market the device to hospitals throughout the United States. EarlySense is an Israeli company with offices in Israel and the U.S. that markets sensors for hospital beds, especially those to help patients connected to many monitoring devices. The sensor is placed under the hospital bed mattress and works by sensing changes in pressure caused by the patient moving in the bed, alerting hospital staff of sudden movements or changes, like when a patient falls out of bed.